Clinical trial

IM and IV SPL026 Drug Product in Healthy Participants

NCT05644093

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention SPL026 IV Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention SPL026 IM Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

IM and IV SPL026 Drug Product in Healthy Participants

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-01-03

PhasePHASE1

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

SPL026 IVDRUG

SPL026 IMDRUG

Sponsors & collaborators

Small Pharma Ltdlead sponsor

Mapped research locations

LondonUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05644093 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.